ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint742,806 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryGenevaSTALICLA SA
STALICLA SA Logo
Verified· 3 sources

STALICLA SA

Summary

About the company

STALICLA SA is a biopharmaceutical company developing precision medicines and clinical programs for neurodevelopmental and neuropsychiatric disorders. It uses the DEPI neuro-precision platform, combining multi-omics, patient data and AI to identify subgroups and match patients with drug treatments.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
✓ Offered6
Precision medicine drug development
Precision medicine drug development for neurodevelopmental and neuropsychiatric disorders, with patient-specific subgroup identification, biomarker-based analysis and clinical development of drug candidates.
DEPI Platform
DEPI platform for patient-drug precision matching, multi-omics analysis, patient stratification, responder subgroup identification and prioritization of drug candidates for targeted therapies.
Clinical development of STP1
Clinical development of STP1 as a fixed combination of ibudilast and bumetanide for an ASD subgroup, including completion of Phase 1b and Phase 2 follow-on development.
Clinical development of STP2
Clinical development of STP2 (SFX-01), a stabilized synthetic sulforaphane formulation for neurodevelopmental disorders and an ASD subgroup, with Phase 1 data and preparation for Phase 2.
Clinical development of STP7
Clinical development of STP7 (Mavoglurant) for an ASD subgroup and for cocaine use disorder, with Phase 2 experience and planned or ongoing additional studies.
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
Press

Media

July 2, 2025Media
Addex Therapeutics leads Stalicla’s CHF 2 million round
startupticker.ch

Knowledge

No knowledge articles yet

Once STALICLA SA has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

STALICLA SA in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank STALICLA SA by reviews, experience and specialisations.

Is this your company?

Claim the company profile of STALICLA SA to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Avenue de Sécheron 15
1202 Geneva

At a glance

Legal form
Corporation
UID
CHE-421.223.128
Founded
2017 · 9 years
Last commercial register change
February 23, 2026
Employees
11 to 20

Similar companies

NS
NovImmune SA
Plan-Les-Ouates
MM
MMV MEDICINES FOR MALARIA VENTURE
Cointrin
MT
MPC Therapeutics SA
Geneva
AA
ADVANCED ACCELERATOR APPLICATIONS INTERNATIONAL SA
Geneva